Disease-Modifying Treatments for Multiple Sclerosis and the Incidence of Neoplasms
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Disease-modifying treatments for multiple sclerosis have not affected the incidence of neoplasms in clinical trials over 3 decades: a meta-analysis with meta-regression
J Neurol 2022 Jan 23;[EPub Ahead of Print], D Papadopoulos, P Gklinos, G Psarros, K Drellia, EM Delicha, T Friede, DD Mitsikostas, RS NicholasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.